Isabell Werth Accuses German Federation Panel of Bias in El Santo Drug Case
9 years ago StraightArrow Comments Off on Isabell Werth Accuses German Federation Panel of Bias in El Santo Drug Case
WARENDORF, Germany, Mar. 11–Isabell Werth has accused the German Equestrian Federation disciplinary commission of bias in considering whether to penalize the Olympic rider for discovery of a forbidden substance in El Santo NRW.
The German FN said it was unable to go ahead with a hearing Monday into the case because of a motion filed by Isabell’s lawyer accusing the panel of bias. A second FN panel will decide on how to deal with the filing.
A decision on how to proceed will be made within two weeks, it said.
The case arose from the finding of cimetidine–a medication typically used in treating stomach problems in both horses and humans–in a routine testing at the Rhinelander horse championship in Langenfeld, Germany in June last year.
Isabell denied having treated the gelding with the substance and the FN conducted an investigation.
She rejected a request to allow the panel to retain jurisdiction over the case.
Isabell has competed El Santo NRW, a 12-year-old gelding (Ehrentusch x Rythme x Rythmus), at Grand Prix for the past three years including on the German team at the 2011 European Championships.
If found responsible and penalized it would be the second offense for Isabell who was suspended in 2009 over a positive doping test for Fluphenazine at Wiesbaden, Germany.